Mar 03, 2021 / 04:40PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good afternoon and welcome to the AbbVie portion of Cowen's 41st Annual Health Care Conference. Representing the company is Mike Severino, who's Vice Chairman and President; Rob Michael, who is Executive Vice President and Chief Financial Officer; and Jeff Stewart, who is Executive Vice President of Commercial Operations.
AbbVie has been a favorite of Cowen for several years. And it's quite simple. We don't think the company's growth prospects, new product portfolio and total return opportunity are reflected in the stock. And we feel this is an opportunity for you, investors, who are participating in this session.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystSo with that, there's lots of ground to cover in the next 30 minutes. Let's jump right in. Let's start with Humira. Perhaps you can just tell us what level of detailing is Humira receiving today? And is there any
Trustpilot
